This content is from: Home
Deals of the week - September 10 2012
Type of Deal | Value | Acquirer | Target | Adviser to acquirer (tax) | Adviser to target (tax) |
Acquisition | $2.6 billion | Valeant Pharmaceuticals International | Medicis Pharmaceutical | Sullivan & Cromwell - Ronald Creamer / Skadden, Arps, Meagher & Flom | Weil, Gotshal & Manges / Latham & Watkins - Nicholas DeNovio |
Acquisition | $944.4 million | Weichai Power | KION | Hengeler Mueller / King & Wood Mallesons | Freshfields Bruckhaus Deringer / Gleiss Lutz |
Acquisition | $767.8 million | Infra-PSP Canada | Grupo Isolux Corsán | Lefosse Advogados / Linklaters | |
Acquisition | $300 million | OTPP | Manabi Minerais | Lefosse Advogados | |
Acquisition | $158.5 million | Warburg Pincus | Endurance Energy | Stikeman Elliott / Willkie Farr & Gallagher | |
Acquisition | $129.8 million | Twin Butte Energy | Waseca Energy | Stikeman Elliott - Julie D’Avignon | |
Acquisition | $116.8 million | FormFactor | Astria Semiconductor Holdings (MicroProbe) | Davis Polk & Wardwell - Rachel Kleinberg | DLA Piper |
Acquisition | $95 million | Meda | Jazz Pharmaceuticals | Covington & Burling - Rob Heller | |
Acquisition | Undisclosed | Franchise Services of North America | Simply Wheelz | Stikeman Elliott / Edinger Associates / Paul Hastings | Sidley Austin / Blake, Cassels & Graydon |
Type of Deal | Value | Issuer/Borrower | Lead managers/arrangers | Adviser to issuer/borrower (tax) | Adviser to lead managers (tax) |
Initial Public Offering | $4.2 billion | Banco Santander (Grupo Financiero Santander) | Barclays / Citigroup / Credit Suisse / Goldman Sachs / JPMorgan / RBC Capital | Davis Polk & Wardwell | Shearman & Sterling |
The material on this site is for financial institutions, professional investors and their professional advisers. It is for information only. Please read our Terms and Conditions and Privacy Policy before using the site. All material subject to strictly enforced copyright laws.
© 2021 Euromoney Institutional Investor PLC. For help please see our FAQ.